GARVAN INSTITUTE OF MEDICAL RESEARCH

Executive Director

Location
Sydney, Australia
Posted
01 Sep 2022
End of advertisement period
30 Sep 2022
Ref
6035
Contract Type
Permanent
Hours
Full Time

The Garvan Institute of Medical Research has now started an international search to succeed Professor Chris Goodnow FRS as the Institute’s next Executive Director. 

The Garvan is one of the world’s top research institutions. For more than 50 years, Garvan has pioneered insights into some of the most widespread diseases by contributing leading research in genomics, cellular genomics and epigenetics; cancer; diseases of immunity and inflammation; and diseases of ageing affecting bone, brain and metabolism.

A team of 900 plus excellent and dedicated researchers and professionals utilising cutting-edge technology and benefitting from dynamic local and international collaborations build the platform of Garvan’s ambition. They seek to enhance and develop research programs that combine fundamental science with strong clinical interaction, harness all the information encoded in our genome, from DNA to complex organ systems, to better diagnose, treat, predict and prevent disease.

This is an outstanding opportunity for an experienced and inspirational leader to guide the Garvan so that it can continue to create a future where everyone lives longer, healthier lives. The successful candidate will combine excellent scientific insight and international standing with leadership experience at levels of scale and complexity that meet the demands of the role. They will bring compelling advocacy, entrepreneurial drive and the ability to mobilise resources that in turn help to realise Garvan’s ambition and potential. A deep commitment to creating an environment that allows everyone to thrive and to achieve a shared vision and goals is essential.

If you wish to discuss this role further please contact Mazin Almaimani at mazin.almaimani@perrettlaver.com or 61 (0) 2 8075 4605, quoting 6035. 

Closing date for applications is 11:59 pm AEST 30th September 2022.